The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: Possible involvement of the serotonergic 5-HT3 receptor

Neuroscience Letters

Volumn 220, Issue 1, 1996, Pages 5-8

  Ferraro, Luca ^a   Tanganelli, Sergio ^b   O'Connor, William Thomas ^c   Antonelli, Tiziana ^a   Rambert, Francis ^d   Fuxe, Kjell ^e  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d Neuropsychopharmacologie   (France)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

aminobutyric acid; medial preoptic area; modafinil; posterior hypothalamus; release

Indexed keywords

4 AMINOBUTYRIC ACID; BEMESETRON; METHYSERGIDE; MODAFINIL; SEROTONIN 3 RECEPTOR; SEROTONIN ANTAGONIST;

ALERTNESS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NEUROTRANSMITTER RELEASE; NONHUMAN; POSTERIOR HYPOTHALAMUS; PREOPTIC AREA; PRIORITY JOURNAL; RAT;

ANIMALS; AROUSAL; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; GAMMA-AMINOBUTYRIC ACID; HYPOTHALAMUS, POSTERIOR; MALE; METHYSERGIDE; PREOPTIC AREA; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN ANTAGONISTS; TROPANES;

EID: 0030573001     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(96)13212-2     Document Type: Article

References (20)

1. 3 receptors mediate inhibition of acetylcholine release in cortical tissue, Nature, 338 (1989) 762-763.
2. [2] Bastuji, H. and Jouvet, M., Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil, Prog. Neuropsychopharmacol. Biol. Psychiatry, 12 (1988) 695-700.
3. [3] Blandina, P., Goldfarb, J., Walcott, J. and Green, J.P., Serotonergic modulation of the release of endogenous norepinephrine from rat hypothalamic slices, J. Pharmacol. Exp. Ther., 256 (1991) 341-347.
4. [4] Cespuglio, R., Houdouin, F., Oulerich, M., El Mansari, M. and Jouvet, M., Axonal and somato-dendritic modalities of serotonin release: their involvement in sleep preparation, triggering and maintenance, J. Sleep Res., 1 (1992) 150.
5. [5] De Sereville, J.E., Boer, C., Rambert, F.A. and Duteil, J., Lack of pre-synaptic dopaminergic involvement in modafinil activity in anaesthetized mice: in vivo voltammetry studies, Neuropharmacology, 33 (1994) 755-761.
6. [6] Duteil, J., Rambert, F.A., Pessonnier, J., Hermant, F., Gombert, R. and Assous, E., Central alpha-1 adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals, Eur. J. Pharmacol., 180 (1990) 279-284.
7. [7] Ferraro, L., Tanganelli, S., O'Connor, W.T., Antonelli, T., Rambert, F.A. and Fuxe, K., The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism, Eur. J. Pharmacol., 306 (1996) 33-39.
8. [8] Fozard, J.R., MDL72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors, Naunyn-Schmiedeberg's Arch. Pharmacol., 326 (1984) 36-44.
9. [9] Fuxe, K., Janson, A.M., Rosen, L., Finnman, U.-B., Tanganelli, S., Morari, M., Goldstein, M. and Agnati, L.F., Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis, Exp. Brain Res., 88 (1992) 117-130.
10. [10] Kehr, J. and Ungerstedt, U., Fast estimation of GABA in microdialysis perfusates: effects of nipecotic acid and 3 mercaptopropionic acid, J. Neurochem., 51 (1989) 1309-1310.
11. [11] Lin, J.S., Sakai, K., Vanni-Mercier, G. and Jouvet, M., A critical role of the posterior hypothalamus in the mechanism of wakefulness determined by microinjection of muscimol in freely moving cats, Brain Res., 479 (1989) 225-240.
12. [12] Lin, J.S., Roussel, B., Akaoka, H., Fort, P., Debilly, G. and Jouvet, M., Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat, Brain Res., 591 (1992) 319-326.
13. [13] Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1982.
14. 3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat, Eur. J. Pharmacol., 249 (1993) 259-264.
15. [15] Simon, P., Hemet, C., Ramassamy, C. and Costentin, J., Nonamphetaminic mechanism of stimulant locomotor effect of modafinil in mice, Eur. Neuropsychopharmacol., 5 (1995) 509-514.
16. [16] Tanganelli, S. and Fuxe, K., Ferraro, L., Janson, A.M. and Bianchi, C., Inhibitory effects of the psychoactive drug modafinil on gamma-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig, Naunyn-Schmiedeberg's Arch. Pharmacol., 345 (1992) 461-465.
17. [17] Tanganelli, S., de la Mora, M.P., Ferraro, L., Mendez-Franco, J., Beani, L., Rambert, F.A. and Fuxe, K., Modafinil and cortical gamma-aminobutyric acid outflow. Modulation by 5-hydoxytryptamine neurotoxins, Eur. J. Pharmacol., 273 (1995) 63-71.
18. [18] Tanganelli, S., Ferraro, L., O'Connor, W.T., Rambert, F.A. and Fuxe, K., The vigilance promoting drug modafinil reduces endogenous GABA release from different regions of mammals, Annual Meeting of the ACNP, San Juan Puerto Rico, December, 1995.
19. [19] Touret, M., Sallanon-Moulin, M. and Jouvet, M., Awakening properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat, Neurosci. Lett., 189 (1995) 43-46.
20. [20] Trulson, M.E. and Jacobs, B.L., Raphe unit activity in freely moving cats: correlation with level of behavioral arousal, Brain Res., 163 (1979) 135.